All In MedTech

Device Trial Radar · NCT03611361

Wound Imaging Study to Gather Clinical References for a Device to Assist Selecting Level-of-amputation in PAD Patients

Wound Imaging System to Gather Clinical References: Collection of Clinical References Images for the Second Generation DeepView Wound Imaging System

Last checked: Nov 20, 2026Latest source record: Apr 17, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

55

Actual

Start

Nov 18, 2015

Primary completion

Jul 2020

Study completion Dec 2020

Sponsor

Lead sponsor
SpectralMDNot on our public-company list
Sponsor type
Industry
Collaborators
Baylor Research Institute
First posted
Aug 2, 2018

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years

Summary

As written by the sponsor on the registry.

This is a proof-of-concept study to collect images to train a CADe algorithm to predict the correct level of amputation in individuals scheduled for amputation secondary to PAD.

Conditions

  • Amputation Wound
  • Peripheral Arterial Disease

Interventions

  • SpectralMD DeepView Wound Imaging System 2.0Device

    The DeepView is an imaging device which simultaneously performs multispectral imaging (MSI) measurements across the visible and infrared spectrum to obtain a quantitative tissue viability assessment. These optical measurements are integrated using a machine learning (ML) algorithm to categorize microvascular blood flow and provide a quantitative assessment for selection of tissue healing.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Standardized amputation healing assessmentTime frame: 30-days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Dr. Dennis Gable

    Plano, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.